Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:08 PM
Ignite Modification Date:
2025-12-24 @ 4:08 PM
NCT ID:
NCT02175966
Eligibility Criteria:
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com.
Inclusion Criteria:
* Males and Females ≥18 years of age, inclusive
* Chronic HCV infection Genotype 1 only
* Non-cirrhotic
* Treatment naive subjects with no previous exposure to an Interferon formulation (ie, IFNα, pegIFNα), ribavirin (RBV) or HCV Direct Acting Antiviral (DAA) (protease, polymerase inhibitor, etc.)
Exclusion Criteria:
* HCV Genotype other than Genotype 1
* Documented or suspected hepatocellular carcinoma
* Evidence of decompensated liver disease
* Contraindication(s) to Peg/RBV therapy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT02175966
Study Brief:
Protocol Section:
NCT02175966